Molecular markers of cardiac fibrosis after myocardial infarction

Molecular markers of cardiac fibrosis after myocardial infarction

Aim. To perform a screening for molecular markers of cardiac fibrosis upon myocardial infarction.Materials and Methods. We carried out echocardiography-guided endomyocardial biopsy of affected and intact interventricular septum segments of 7 patients with anterior myocardial infarction. Fibrotic and...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. L. Barbarash, A. G. Kutikhin, T. B. Pecherina, R. S. Tarasov, V. V. Kashtalap, N. V. Fedorova, L. A. Bogdanov, O. N. Hryachkova, D. Yu. Sedykh
Format:	Article
Language:	Russian
Published:	Kemerovo State Medical University 2022-03-01
Series:	Фундаментальная и клиническая медицина
Subjects:	myocardial infarction cardiac fibrosis molecular markers agtr1 ccl2 tnf
Online Access:	https://fcm.kemsmu.ru/jour/article/view/511
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Echocardiographic correlates of cardiac fibrosis in patients with myocardial infarction and preserved left ventricular ejection fraction
by: N. V. Fedorova, et al.
Published: (2019-06-01)

Predictors of myocardial fibrosis and loss of epicardial adipose tissue volume in the long-term period after myocardial infarction
by: O. L. Barbarash, et al.
Published: (2020-03-01)

Fibrosis biomarkers and global myocardial strain in the diagnosis and prediction of diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-07-01)

In-hospital changes of echocardiographic parameters and their relationship with the procollagen I C-terminal propeptide in patients with myocardial infarction and preserved left ventricle systolic function
by: A. V. Osokina, et al.
Published: (2020-03-01)

Participation of the C-terminal propeptide procollagen type I in the formation of cardiofibrosis in patients with myocardial infarction with preserved left ventricular ejection fraction
by: A. V. Osokina, et al.
Published: (2021-03-01)

Three Year Prognosis of Patients with Myocardial Infarction Depending on the Body Weight Index: Data of the Kemerovo Acute Coronary Syndrome Registry
by: D. Yu. Sedykh, et al.
Published: (2022-03-01)

THE STUDY OF RS1800629 (G-308А) POLYMORPHISM OF THE TNF GENE IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ELEVATED ST SEGMENT
by: M. V. Zykov, et al.
Published: (2014-10-01)

Non-ST segment elevation myocardial infarction: results of 2021−2022
by: O. L. Barbarash, et al.
Published: (2023-04-01)

Clinical and prognostic significance of matrix metalloproteinases in patients with myocardial infarction
by: T. B. Pecherina, et al.
Published: (2019-06-01)

Serum markers of cardiac fibrosis suffering from heart failure with preserved left ventricular ejection fraction upon ST-segment elevation myocardial infarction
by: A. V. Оsokina, et al.
Published: (2021-09-01)

Healthy nutrition in secondary prevention after myocardial infarction. What to focus on?
by: O. L. Barbarash, et al.
Published: (2022-01-01)

The role of matrix metalloproteinases in left ventricular remodeling in patients with ST-segment elevation myocardial infarction
by: T. B. Pecherina, et al.
Published: (2019-06-01)

Biomarkers of myocardial fibrosis and their genetic regulation in patients with heart failure
by: T. B. Pecherina, et al.
Published: (2020-11-01)

POLYMORPHISM OF ANGIOTENSIN II ALFA-GENE OF THE 1<sup>ST</sup> TYPE IN CHILDREN WITH SECONDARY HYPERTENSION
by: L. I. Kolesnikova, et al.
Published: (2014-04-01)

Remote active monitoring of patients after myocardial infarction: are there any advantages over standard outpatient monitoring?
by: D. Yu. Sedykh, et al.
Published: (2024-06-01)

EFFECT OF STATINS ON SERUM CONCENTRATION OF INFLAMMATORY MARKERS AND MATRIX METALLOPROTEINASES IN PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: TAMARA B. Pecherina, et al.
Published: (2019-03-01)

ROLE OF THE SERUM NGAL FOR ASSESSMENT OF HOSPITAL PROGNOSIS IN MEN WITH ST ELEVATION MYOCARDIAL INFARCTION
by: V. N. Karetnikova, et al.
Published: (2015-06-01)

FOURTH UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. FOCUS ON THE TYPE 2 MYOCARDIAL INFARCTION
by: OLGA L. Barbarash, et al.
Published: (2018-12-01)

Pro-inflammatory cytokines and depression in myocardial infarction
by: O. L. Barbarash, et al.
Published: (2011-04-01)

Predictors of ischemic and hemorrhagic complications in patients with myocardial infarction at 18-month follow-up: a single-center registry study
by: V. V. Kashtalap, et al.
Published: (2023-06-01)

Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries
by: O. L. Barbarash, et al.
Published: (2020-05-01)

Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo)
by: D. Yu. Sedykh, et al.
Published: (2020-01-01)

An antioxidant nanozyme for targeted cardiac fibrosis therapy post myocardial infarction
by: Ziyi Gu, et al.
Published: (2024-12-01)

COMPARISON OF IN-HOSPITAL LETHALITY PROGNOSTIC SCALES IN MYOCARDIAL INFARCTION PATIENTS
by: M. V. Zykov, et al.
Published: (2012-02-01)

Modern ways to reduced mortality of myocardial infarction. What should be done?
by: O. L. Barbarash, et al.
Published: (2023-10-01)

INSULIN RESISTANCE MARKERS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2011-12-01)

N-terminal propeptide of type III procollagen for predicting diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-02-01)

RESULTS OF ENDOVASCULAR REVASCULARIZATION IN ELDERLY PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION IN MULTIVESSEL DISEASE
by: A. M. Kochergina, et al.
Published: (2016-03-01)

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction
by: O. L. Barbarash, et al.
Published: (2013-06-01)

Low‐dose TNF augments fracture healing in normal and osteoporotic bone by up‐regulating the innate immune response
by: James K Chan, et al.
Published: (2015-03-01)

Early diagnosis of myocardial fibrosis in patients with epicardial obesity
by: O. V. Gritsenko, et al.
Published: (2021-04-01)

CLINICAL AND PROGNOSTIC VALUE OF INTERLEUKIN-12 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: M. V. Zykov, et al.
Published: (2014-07-01)

Biomarkers of inflammation and endothelial dysfunction in elderly patients with myocardial infarction, hypertension and frailty
by: N. M. Agarkov, et al.
Published: (2023-04-01)

FEATURES OF THE CLINICAL SIGNIFICANCE OF POLYMORPHIC VARIANTS OF ENOS AND AGTR2 GENES IN PATIENTS WITH CAD
by: A. L. Khokhlov, et al.
Published: (2016-06-01)

Remote myocardial fibrosis predicts adverse outcome in patients with myocardial infarction on clinical cardiovascular magnetic resonance imaging
by: Nicholas Black, et al.
Published: (2024-01-01)

IMPORTANCE OF CARDIAC AND PULMONARY HEMODYNAMICAL VALUES IN VARIOUS PERIODS OF MYOCARDIAL INFARCTION FOR EARLY DIAGNOSING POSTINFARCTIONAL HEART REMODELING
by: N. I. Tarasov, et al.
Published: (2001-02-01)

GENETIC MARKERS OF MYOCARDIAL FIBROSIS: OPPORTUNITY TO PREDICT ADVERSE OUTCOMES IN AORTIC STENOSIS
by: Т. A. Tipteva, et al.
Published: (2018-03-01)

Myeloid‐Derived Suppressor Cell Accumulation Drives Intestinal Fibrosis through mCCL6/hCCL15 Chemokine‐Mediated Fibroblast Activation
by: Xiaohui Cheng, et al.
Published: (2025-02-01)

SPECIAL FEATURES OF REHABILITATION AND OUTCOME PREDICTION IN MYOCARDIAL INFARCTION COMPLICATED BY ARRHYTHMIAS
by: N. I. Tarasov, et al.
Published: (2001-06-01)

CLINICAL AND PREDICTIVE VALUE OF SERUM INTERLEUKINE-18 IN ST ELEVATION MYOCARDIAL INFARCTION
by: M. V. Zykov, et al.
Published: (2015-11-01)